Immunotherapy for glioblastoma: are we finally getting closer?
- PMID: 25964313
- PMCID: PMC4483131
- DOI: 10.1093/neuonc/nov070
Immunotherapy for glioblastoma: are we finally getting closer?
Comment on
-
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.Neuro Oncol. 2015 Jun;17(6):854-61. doi: 10.1093/neuonc/nou348. Epub 2015 Jan 13. Neuro Oncol. 2015. PMID: 25586468 Free PMC article. Clinical Trial.
References
-
- Weiss SA, Chandra S, Pavlick AC. Update on vaccines for high-risk melanoma. Curr Treat Options Oncol. 2014;15(2):269–280. - PubMed
-
- Jacobs JJ, Snackey C, Geldof AA, et al. Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer. Anticancer Res. 2014;34(6):2689–2700. - PubMed
-
- Waziri A. Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin N Am. 2010;21(1):31–42. - PubMed
-
- Lampson LA. Brain tumor immunotherapy: seeing the brain in the body. Drug Discov Today. 2013;18(7–8):399–406. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical